Searched for
HEARING AID MARKET
Sonova unveils new AI-powered hearing-aid platform to support growth targetsThe Swiss company was the first one to roll out a hearing aid that used real-time AI to separate speech from background noise in 2024.- CAS chaos: Nifty ends flat but Sensex jumps 374 points on expiry dayIndian markets closed higher with Sensex rising 374 points, while Nifty remained flat due to divergence from the closing auction session. P...
- US stocks: SpaceX quarterly revenue surges in debut results on strong growth in its Starlink businessSpaceX has announced an impressive 92% increase in revenue for the latest quarter, primarily fueled by the growth of Starlink and its AI in...
- Regime change? Inside Reza Pahlavi's faltering bid to lead IranReza Pahlavi, the exiled son of Iran's last shah, is facing growing questions over his leadership ambitions despite years of campaigning fo...
- Own a good business: Volatility, Iran, Trump will all be taken care of. 7 large-cap stocks with upside potential of up to 33%There was a time when many investors said with pride that they owned only blue chips. Today, there are probably only a few of them left. An...
- India to chair 9th UN Intergovernmental Group of Experts session on consumer protection in GenevaIndia is set to chair the UNCTAD's Intergovernmental Group of Experts on Consumer Protection Law and Policy in Geneva. The session will foc...
- India has Rs 95,000 cr addressable market for assistive tech by 2030: NCPEDPIndia's assistive technology market could reach Rs 95,000 crore by 2030 with a dedicated national policy, experts revealed. This sector, cr...
- Mukul Agarwal picks 7.6% stake in this multibagger stock that’s up over 200% in just 1 yearOsel Devices rose sharply after Mukul Agarwal picked up a 7.6% stake in the multibagger smallcap, which has surged over 200% in the past ye...
- Earkart shares list flat at IPO price of Rs 135 on BSE SME platformEarkart shares debuted flat on the BSE SME platform at Rs 135.5. The IPO price was Rs 135. The issue saw 1.28 times overall subscription. N...
- AirPods aren't just for music anymore- Could Apple be shaping the future of hearing aids?Apple plans to introduce a hearing aid mode in its AirPods Pro 2, making them the first software-based hearing aids. This feature includes ...
- EarKart raises funding from Agility Ventures, othersEarKart, a hearing aid technology firm, has raised an undisclosed amount of pre-Series A funding led by Agility Ventures.
- US citizens to get affordable hearing aids soon. Here's howUS looks to roll out affordable hearing aids for numerous beneficiaries at the earliest. Over 30 million people may get access to these aid...
- Goyal suggests Cochlear Ltd to set up manufacturing base in IndiaSydney-based Cochlear is a global leader in implantable hearing solutions. At a luncheon meeting with businesses of India and Australia, Go...
- Sebi should hear companies' views on splitting CMD roles, says FM Nirmala SitharamanIn a post-budget interaction with captains of industry, Sitharaman exhorted India Inc to "quickly" step up capital expenditure to aid the v...
- Antitrust hearing: Did a tech glitch help Jeff Bezos escape early questions?Poor audio quality, flat-screen televisions going off, chief executives appearing together as thumbnails on a large screen - led to observe...
- European shares fall as risk-off sentiment spreadsIn Italy the FTSE MIB was down 1.4 per cent to its lowest since 21 April 2017.
- From a mini teleprompter to an e-skin for monitoring health, tech developments that will make life simplerThere's also a stylish new way to deodorise your shoes.
- Crop damage by unseasonal rains, hailstorm a serious issue: HC"The loss of crops, which were about to be harvested and taken to the market for sale, comes up to Rs 42,000 crore approximately," the PIL ...
- IPL spot fixing scandal: Court to hear bail pleas on August 16A Delhi court today fixed August 16 for hearing the bail pleas of eight accused, including suspended Rajasthan Royals player Ajit Chandila.
- Gilead to launch generic VireadUS-based biopharmaceutical firm Gilead Sciences on Friday will launch generic versions of its HIV/AIDS drug 'Viread' in the next 3-6 months...
Load More
